Emerging research has connected insulin resistance to various neurodegenerative processes in AD through pathways involving oxidative stress, mitochondrial dysfunction, and chronic liver inflammation, all contributing to neurodegeneration and cerebrovascular damage, which impact brain metabolism and lead to cognitive decline [7]. This evidence concerns the gene INS and Alzheimer disease.